Additional well-powered studies are required to confirm the effect of multiple HFE mutations (C282Y, H63D and S65C) on the susceptibility to different types of NAFLD, liver cirrhosis and HCC. This evidence concerns the gene HFE and metabolic dysfunction-associated steatotic liver disease.